It's likely that most major health insurers will participate in the insurance exchanges that must be up and running in each state by 2014, according to experts.
NATIONAL REPORTS-It's likely that most major health insurers will participate in the insurance exchanges that must be up and running in each state by 2014 under the Patient Protection and Affordable Care Act (PPACA), experts predict. And most states are likely to set up their own exchanges rather than let the federal government do it.
The exchanges and new insurance rules could foster greater competition and force insurers to operate more efficiently and transparently.
"I believe larger insurers are going to need to be part of the exchanges from a sheer volume perspective," says Maureen Fahey, the national healthcare reform leader for KPMG. "They'll have to balance a lower-margin, higher-volume book of business that's consumer driven. It's a new paradigm."
"We want to make sure we offer opportunities for consumers to continue to purchase the kind of plans they want to buy today," says Donna Zimmerman, senior vice president for government and community relations at HealthPartners, a not-for-profit health plan and health system based in Bloomington, Minn. "As the government sets up the exchanges, it should think about mechanisms to allow those plans to continue to be sold."
The state-based American Health Benefit Exchanges and Small Business Health Options Program Exchanges are central features of PPACA. Every state, or group of states, must offer an exchange so individuals and small businesses of up to 100 employees can select from an array of plans. Lower- and middle-income individuals and families will receive a subsidy to buy coverage through the exchanges. Larger businesses will be able to buy through the exchanges beginning in 2017.
The federal Office of Personnel Management (OPM) must contract with insurers to offer at least two multi-state plans in each exchange, one of which must be not-for-profit. Federal grants will be available to start not-for-profit consumer cooperative plans, which will qualify to market in the exchanges.
Requiring insurers to sell the same standard packages both inside and outside the exchanges lessens the incentive for insurers to sell solely outside the exchanges, says Sara Collins, vice president of the affordable health insurance initiative at the Commonwealth Fund in New York. They won't be able to sell leaner packages to attract younger, healthier customers.
Except for grandfathered plans, products sold both inside and outside the exchanges must conform to four standard benefit designs with different cost-sharing levels; a separate catastrophic package will be available to people aged 30 and under.
Walton Francis, principal author of Checkbook's Guide to Health Plans for Federal Employees, which helps federal workers navigate the Federal Employees Health Benefit Program (FEHBP), says launching the new exchanges by 2014 is entirely doable. States can follow the existing exchange models of the FEHBP, Massachusetts Health Connector, Medicare Advantage and Medicare Part D. He worries, though, that the standard benefit packages required by the new exchanges will be too rich-and expensive.
"The imperative will be to cover more and keep copayments and coinsurance low," he says.
Francis also is concerned about whether insurers will see the exchange risk pools as broad and viable, allowing them to set their premiums appropriately. He cites the Massachusetts experience, where some people have defied the mandate and bought coverage only after getting sick.
"If plans think they'll be forced to operate at a loss, they won't bid, or they'll pull out," he says.
That scenario could happen, he says, should the courts strike down the reform law's mandate mechanism as unconstitutional.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More